The molecular landscape of CR-mut in GBM, IDH-WT, and astrocytoma, IDH-mut tumors include increased mutations in multiple genes of previously demonstrated prognostic or therapeutic value. The gene discussed is IDH1; the disease is astrocytoma (excluding glioblastoma).